SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-034527
Filing Date
2024-03-14
Accepted
2024-03-14 16:30:25
Documents
14
Period of Report
2024-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248844d1_8k.htm   iXBRL 8-K 21910
  Complete submission text file 0001104659-24-034527.txt   191731

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20240308.xsd EX-101.SCH 3006
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20240308_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20240308_pre.xml EX-101.PRE 22353
15 EXTRACTED XBRL INSTANCE DOCUMENT tm248844d1_8k_htm.xml XML 3518
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 24750634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)